Results 181 to 190 of about 83,570 (294)
710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE) [PDF]
Chelsea E Jones +4 more
openalex +1 more source
Emergence of Carbapenem-Resistant Hypervirulent ST111 K63 <i>Klebsiella pneumoniae</i> in China. [PDF]
Zhu Y +9 more
europepmc +1 more source
"Overview of Carbapenem-Resistant Enterobacteriaceae" [PDF]
openaire +1 more source
Precision Approaches to Carbapenem-Resistant Infections in the ICU: Integrating Diagnostics, Stewardship, and Novel Therapies. [PDF]
Morena R +3 more
europepmc +1 more source
Carbapenem-Resistant Enterobactericeae: ClinicoEpidemiological Perspective.
Since its first discovery in 1996, Carbapenem-resistant Enterobactericeae (CRE) has been increasingly reported as a cause of infections particularly in immunocompromised patients. With limited treatment options, these multidrug-resistant organisms are associated with high mortality rates and are now recognized as an important cause of health-care ...
N A, Mohamed +4 more
openaire +1 more source
Therapeutic challenges and emerging strategies against carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]
Yang C, Li J, Luo X, Song Z, Zhang J.
europepmc +1 more source
Vital signs: carbapenem-resistant Enterobacteriaceae.
Enterobacteriaceae are a family of bacteria that commonly cause infections in health-care settings as well as in the community. Among Enterobacteriaceae, resistance to broad-spectrum carbapenem antimicrobials has been uncommon. Over the past decade, however, carbapenem-resistant Enterobacteriaceae (CRE) have been recognized in health-care settings as a
openaire +1 more source

